COMP <GO>
CRON vs MRK // FREE CASH FLOW YIELD
Cronos Group Inc. Common Share (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: CRON 3
— MRK 8
▲ FREE CASH FLOW YIELD LEADER: MRK
LAST: $3.30 (-1.79%) • MKT CAP: $1.24B
fcf-yield
0.01%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
fcf-yield
3.42%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CRON VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CRON | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 42.80% | 74.80% | -32.00 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -4.50% | 20.70% | -25.20 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 0.01% | 3.42% | -3.41 | MRK | /fcf-yield <GO> |
| Operating Margin | -11.90% | 34.30% | -46.20 | MRK | /operating-margins <GO> |
| Net Profit Margin | -2.00% | 28.10% | -30.10 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 24.60% | 1.30% | +23.30 | CRON | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 15.20 | 5.19 | +10.01 | CRON | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.0 | 51.7 | +3.30 | CRON | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.24B | $361.02B | -$359.78B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CRON REV | MRK REV | CRON GROSS % | MRK GROSS % | CRON FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $146.6M | $65.01B | 42.8% | 74.8% | $149.0K | $12.36B |
| FY 2024 | $117.6M | $64.17B | 21.4% | 76.3% | $6.4M | $18.10B |
| FY 2023 | $87.2M | $60.12B | — | — | -$42.8M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CRON // BETA —
MRK // BETA 0.92